Market Size of Nigeria Clinical Laboratory Services Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 4.70 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Nigeria Clinical Laboratory Services Market Analysis
During the time frame of the forecast, the Nigerian clinical laboratory services market is expected to register a CAGR of almost 4.7%.
The clinical laboratory market was affected by the COVID-19 pandemic. However, the COVID-19 diagnostic services positively impacted the market due to the upsurge in COVID-19 cases and the high demand for COVID-19 diagnostic services in Nigeria. According to an article published in the International Journal of Infectious Diseases, the incidence rate of COVID-19 infection was high in Nigeria. The Government of Nigeria continuously focused on remote diagnostics, case management, and expanding telemedicine solutions to fulfill unmet needs during the pandemic. However, currently, the market is growing at a stable pace owing to the resumption of all laboratory services and diagnosis procedures, and it is expected to witness a similar trend over the coming years.
The Nigerian clinical laboratory market is driven by the rise of chronic diseases, the growing need for accurate disease diagnosis, and the government's focus on public-private partnerships. According to the Global Health Data Exchange 2020, malaria, lower respiratory infections, HIV/AIDS, diarrheal diseases, cancer, meningitis, stroke, and tuberculosis are the leading causes of death in Nigeria.The number of malaria cases was around 58.1 million. In addition, according to the World Health Organization Report 2021, in Nigeria, the number of tuberculosis cases was 2.9 million and the number of cases of diarrheal diseases was around 244.5 million. Thus, the prevalence of infectious diseases is rising in the country, augmenting the demand for diagnostic services for the better management of diseases.
Furthermore, the Nigerian government, donor agencies, and non-governmental organizations (NGOs) are working together to make people more aware. 54 Gene announced the launch of its diagnostic arm, 7RiverLabs, in December 2021. The diagnostic hubs are fitted with state-of-the-art technology that will offer healthcare providers and patients access to world-class, cost-effective, speedy, reliable, and advanced molecular diagnostics. However, the lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff restrain the growth of the market studied.
